Results 61 to 70 of about 32,249 (192)

An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults

Human Vaccines & Immunotherapeutics
The 20-valent pneumococcal conjugate vaccine (PCV20) was developed to expand protection against vaccine-preventable disease caused by Streptococcus pneumoniae beyond the 13-valent pneumococcal conjugate vaccine (PCV13).
Kathleen McElwee, Jelena Vojicic, Charulata Sabharwal, John Ginis, Yahong Peng, Gabriel Mircus, Wendy Watson, Annaliesa Anderson   +7 more
doaj   +1 more source

Health and Survival Impacts of Early Childhood Development Programmes: The Case of the Happy Child Programme in Brazil

Review of Development Economics, EarlyView.
ABSTRACT This paper adds to the growing evidence on the impacts of early childhood development (ECD) programming by examining one of the world's largest home visitation programmes, the Happy Child Programme in Brazil, and its impacts on child vaccination and preventable death rates.
Raquel Tebaldi, Franziska Gassmann, Bruno Martorano   +2 more
wiley   +1 more source

Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study

The Lancet Public Health
Summary: Background: Paediatric pneumococcal conjugate vaccine (PCV) programmes in England using seven-valent PCV (PCV7) in 2006 and 13-valent PCV (PCV13) in 2010 have reduced vaccine-type invasive pneumococcal disease, but the overall effect has been ...
Yoon Hong Choi, PhD, Marta Bertran, MSc, David J Litt, PhD, Shamez N Ladhani, ProfPhD, Elizabeth Miller, ProfFMedSci   +4 more
doaj   +1 more source

Will Extended‐Valency Pneumococcal Conjugate Vaccines Offer Enhanced Coverage Against Invasive Pneumococcal Disease for At‐Risk Children?

Acta Paediatrica, EarlyView.
Robert Cohen, Corinne Levy, Naim Ouldali, Stéphane Béchet, Aude Estivaux, André Birgy, Isabelle Hau, IPD Study Group, Emmanuelle Varon   +8 more
wiley   +1 more source

Artificial Intelligence Resources for the Screening of Titles and Abstracts in Systematic Reviews: A Scoping Review

Cochrane Evidence Synthesis and Methods, Volume 4, Issue 5, September 2026.
ABSTRACT Introduction Artificial intelligence (AI) is a branch of technology enabling machines to emulate complex human skills; it can also entail problem‐solving using bioinspired methods. It is used for automating systematic literature reviews (SLR), that is, defining a clinical question, locating relevant literature, preliminary screening, study ...
Ana M. Barragán, Sara Elena Ortiz Bonett, Eliana‐Isabel Rodríguez‐Grande, Alvaro David Orjuela‐Cañón, Oscar J. Perdomo, Guillermo Sánchez‐Vanegas   +5 more
wiley   +1 more source

Stillbirth, Neonatal, and Child Mortality in Bangladesh: Progress and Persistent Public Health Challenges

Public Health Challenges, Volume 5, Issue 3, September 2026.
ABSTRACT Bangladesh made substantial gains in child survival over two decades, with the under‐five mortality rate falling from 94 to 30 per 1000 live births between 2000 and 2020. Recent data from the Bangladesh Bureau of Statistics, however, point to a troubling reversal.
Md. Siddikur Rahman, Md. Abu Bokkor Shiddik   +1 more
wiley   +1 more source

Expert panel opinion on adult pneumococcal vaccination in the post-COVID era (NAP- EXPO Recommendations-2024)

Lung India
Introduction Pneumococcal diseases pose a significant public health concern in India, with substantial morbidity and mortality, with the elderly and those with coexisting medical conditions being most at risk.
Parvaiz A. Koul, Agam C. Vora, Surinder K. Jindal, Venkatasubramanian Ramasubramanian, Varsha Narayanan, Surya Kant Tripathi, Digambar Bahera, Harway Bhaskar Chandrashekhar, Ravindra Mehta, Narendra Raval, Prabhakar Dorairaj, Prashant Chhajed, Akash Balki, Rohan Ketan Aurangabadwalla, Abhijeet Khandelwal, Mahendra Kawedia, Satya Prakash Rai, Ashok Grover, Manish Sachdev, Surajit Chatterjee, Velamuru V. Ramanaprasad, Aratrika Das, Mahavir Madhavdas Modi   +22 more
doaj   +1 more source

Comprehensive Immunisation Among Children Aged 12–23 Months in India—A Multilevel Modelling Analysis From the National Family Health Survey (2015–21)

Public Health Challenges, Volume 5, Issue 3, September 2026.
ABSTRACT Under‐5 child mortality due to vaccine preventable diseases (VPDs) contributes to an estimated burden of ∼5.2 million deaths globally, mostly within low‐ and middle‐income countries (LMICs). Despite ongoing efforts to expand immunisation coverage, gaps in immunisation remain a persistent public health concern, underscoring the need to examine ...
Mansi Malik, Saurav Basu, Siaa Girotra, Satyajit Kundu   +3 more
wiley   +1 more source

The Impact of Clinical Pharmacist on the Intention of Hemodialysis Patients to Receive Pneumococcal Vaccination: Cross sectional study

Pharmata
Objective: There is limited data on the coverage of the pneumococcal vaccine among dialysis patients. The role of pharmacists in increasing vaccine acceptance has become increasingly evident.
Songül Aslancı, Hanife Avcı, Kamer Tecen   +2 more
doaj   +1 more source

A 5‐Year Retrospective Morbidity Profile of School‐Aged Children at Ho Polyclinic, Volta Region, Ghana: Skin Conditions, Malaria, and Respiratory Illnesses as Leading Causes (2018–2022)

Public Health Challenges, Volume 5, Issue 3, September 2026.
Analysis of 10,428 outpatient consultations among school‐aged children attending Ho Polyclinic, Ghana (2018–2022), showed that three conditions accounted for 77.4% of all morbidity: skin conditions (38.3%), malaria (23.0%), and respiratory conditions (16.1%).
Anthoinette Adesope Ekuban, Frank Baiden
wiley   +1 more source